US FDA accepts BLA for Sobi's Nanoecapsulated Siro...
Category : Approval/Launch 11 September 2025"Sobi, a global biopharmaceutical company dedicated to delivering innovative treatments for pat...
 
          "Sobi, a global biopharmaceutical company dedicated to delivering innovative treatments for pat...
 
          Bayer has launched Bayer Co.Lab AdVenture, a new platform within its global life sciences incubator...
 
          Takeda announced that the US Food and Drug Administration (FDA) has approved the supplemental Biolog...
 
          Evommune, Inc. has dosed the first patient in its Phase 2b trial of EVO756, an oral small molecule d...
 
          Navamedic, a Nordic pharma player, just hit a key milestone. The company has received final approval...